Shire Pays $57.5M To End ADHD Drug Marketing Probe
Irish drugmaker Shire PLC said Friday that it has agreed to pay $57.5 million to resolve a U.S. investigation led by the U.S. Attorney's Office for the Eastern District of Pennsylvania...To view the full article, register now.
Already a subscriber? Click here to view full article